A Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Individuals With Major Depressive Disorder
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Feb 2015 Biomarkers information updated
- 21 Jun 2013 Planned end date changed from 1 Dec 2009 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 28 Dec 2007 New trial record.